UROONCOLOGY - Original Article

Pathological Accuracy in Prostate Cancer: Single-Center Outcomes of 3 Different Magnetic Resonance Imaging-Targeted Biopsy Techniques and Random Systematic Biopsy

Volume 48 · Issue 5 Publish Date: September 1, 2022
Full Text PDF
DOI
Mert Kılıç
Department of Urology, VKF American Hospital, İstanbul, Turkey
Mevlana Derya Balbay
Department of Urology, Koç University Faculty of Medicine, İstanbul, Turkey
Yakup Kordan
Department of Urology, Koç University Faculty of Medicine, İstanbul, Turkey
Abdullah Erdem Canda
Department of Urology, Koç University Faculty of Medicine, İstanbul, Turkey
Dilek Ertoy Baydar
Department of Pathology, Koç University Faculty of Medicine, İstanbul, Turkey
Ersin Köseoğlu
Department of Urology, Koç University Faculty of Medicine, İstanbul, Turkey
Barbaros Erhan Çil
Department of Radiology, Koç University Faculty of Medicine, İstanbul, Turkey
Bülent Çolakoğlu
Department of Radiology, VKF American Hospital, İstanbul, Turkey
Metin Vural
Department of Radiology, VKF American Hospital, İstanbul, Turkey
Ömer Acar
Department of Urology, Koç University Faculty of Medicine, İstanbul, Turkey
Tarık Esen
Department of Urology, Koç University Faculty of Medicine, İstanbul, Turkey
Full Text Full Text PDF

Abstract

Objective: The aim of this study is to compare systematic, cognitive fusion, in-bore, and software fusion prostate biopsies regarding rates of and risk factors for pathological upgrading.

Material and methods: Charts of 291 patients with systematic biopsy (n = 105), magnetic resonance imaging- targeted cognitive fusion (n = 58), in-bore (n = 68), and software fusion biopsy (n = 60), and who subsequently underwent radical prostatectomy were retrospectively evaluated. The degree of similarity between the grade groups reported in the biopsy and radical prostatectomy pathology results was recorded. Analyses of the associated factors for concordance and discordance were performed with univariate and multivariate methods.

Results: The concordance rates were as follows: systematic biopsy = 42.8%, cognitive fusion-targeted biopsy = 50%, in-bore fusion-targeted biopsy = 61.8, and software fusion biopsy = 58.4%. The upgrade rate of systematic biopsy (46.6%) was higher than cognitive fusion-targeted biopsy (27.6%), in-bore fusiontargeted biopsy (26.4%), and software fusion-targeted biopsy (18.3%). The number of positive cores was significantly associated with grade group concordance for the systematic biopsy group (P = .040). Within the cognitive fusion-targeted biopsy cohort, number of positive cores was the only parameter that exhibited a significant association with grade group concordance in multivariate analysis (P = .044). Considering the in-bore fusion-targeted biopsy group, maximum tumor length was statistically significant (P = .021). In the software fusion-targeted biopsy group, low prostate volume was found to be the only significant predictor for grade group accordance (P = .021).

Conclusion: Magnetic resonance imaging-targeted biopsy techniques showed higher concordance and lower upgrade rates compared to systematic biopsy. For systematic biopsy and cognitive fusion-targeted biopsy, the number of positive cores was associated with grade group concordance, while maximum tumor length in in-bore fusion-targeted biopsy and low prostate volume for in-bore fusion-targeted biopsy were associated with grade group concordance. Among the MRI-targeted biopsy methods, in-bore fusion-targeted biopsy and software fusion-targeted biopsy were more accurate than cognitive fusion-targeted biopsy in terms of grade group.

Cite this article as: Kılıç M, Acar Ö, Vural M, et al. Pathological accuracy in prostate cancer: Single-center outcomes of 3 different magnetic resonance imaging-targeted biopsy techniques and random systematic biopsy. Turk J Urol. 2022;48(5):346-353.

Similar Articles

Article Info
Published In
Journal Urology Research & Practice
Volume / Issue Volume 48 · Issue 5
Pages 346-353
History
Published Online September 1, 2022
Copyright
Affiliations
Mert Kılıç
Department of Urology, VKF American Hospital, İstanbul, Turkey
Mevlana Derya Balbay
Department of Urology, Koç University Faculty of Medicine, İstanbul, Turkey
Yakup Kordan
Department of Urology, Koç University Faculty of Medicine, İstanbul, Turkey
Abdullah Erdem Canda
Department of Urology, Koç University Faculty of Medicine, İstanbul, Turkey
Dilek Ertoy Baydar
Department of Pathology, Koç University Faculty of Medicine, İstanbul, Turkey
Ersin Köseoğlu
Department of Urology, Koç University Faculty of Medicine, İstanbul, Turkey
Barbaros Erhan Çil
Department of Radiology, Koç University Faculty of Medicine, İstanbul, Turkey
Bülent Çolakoğlu
Department of Radiology, VKF American Hospital, İstanbul, Turkey
Metin Vural
Department of Radiology, VKF American Hospital, İstanbul, Turkey
Ömer Acar
Department of Urology, Koç University Faculty of Medicine, İstanbul, Turkey
Tarık Esen
Department of Urology, Koç University Faculty of Medicine, İstanbul, Turkey
Cite this Article
Outlines